Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

INTRODUCTION: To sustain the achievement of kala-azar elimination program (KEP), early detection and treatment of the visceral leishmaniasis (VL) cases and associated modalities such as treatment failure (TF), relapse VL (RVL), and Post-kala-azar dermal leishmaniasis (PKDL) is the cornerstone. A pre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Microbiol
Auteurs principaux: Mondal, Dinesh, Ghosh, Prakash, Chowdhury, Rajashree, Halleux, Christine, Ruiz-Postigo, Jose A., Alim, Abdul, Hossain, Faria, Khan, Md Anik Ashfaq, Nath, Rupen, Duthie, Malcolm S., Kroeger, Axel, Matlashewski, Greg, Argaw, Daniel, Olliaro, Piero
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Microbiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795025/
https://ncbi.nlm.nih.gov/pubmed/31649631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.02268
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires